Sunitinib Malate Capsule
Product Images NDC 59651-466

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sunitinib Malate (NDC 59651-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Sunitinib Fig1)

A Kaplan-Meier survival curve chart showing time to tumor progression (%) over weeks for Sunitinib Malate versus placebo. The chart includes median progression times of 27.3 weeks for Sunitinib Malate and 6.4 weeks for placebo, with hazard ratio and confidence interval data presented.*

FDA Label Image

Package Label-principal Display Panel (37.5 mg 28 Capsules (4 x 7 Unit-Dose))

Box packaging for Sunitinib Malate Capsules 37.5 mg, containing 28 capsules (4 x 7 unit-dose). The label states it is for prescription use only and includes storage instructions. Labeler is Aurobindo Pharma Limited, with distribution by Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (50 mg (28 Capsules Bottle))

Label for Sunitinib Malate Capsules 50 mg by Aurobindo Pharma Limited, containing 28 oral capsules. The label includes storage instructions, medication guide dispensing information, distributor details (Aurobindo Pharma USA, Inc.), and notes that each capsule contains 50 mg sunitinib equivalent to 66.83 mg sunitinib malate.*

FDA Label Image

Package Label-principal Display Panel (50 mg 28 28 Capsules (4 x 7 Unit-Dose))

Packaging label for Sunitinib Malate Capsules 50 mg by Aurobindo Pharma Limited. The carton contains 28 capsules in 4 unit-dose blister packs of 7 capsules each. The label includes storage instructions, dosing reference, and pharmacy dispensing information. Distributed by Aurobindo Pharma USA, Inc., made in India with NDC 59651-467-29.*

FDA Label Image

Figure (Sunitinib Fig2)

A Kaplan-Meier curve chart showing time to tumor progression probability (%) over weeks for Sunitinib Malate versus placebo groups. The chart compares progression in patients treated with Sunitinib Malate (median 27.3 weeks) and placebo (median 6.4 weeks), indicating a significant difference in progression rates between the two groups.*

FDA Label Image

Figure (Sunitinib Fig3)

A Kaplan-Meier survival curve graph depicting disease-free survival probability (%) over time (years) for SUNITINIB MALATE versus placebo groups. The solid line represents SUNITINIB MALATE (N=309) with median survival of 6.8 years, and the dashed line represents placebo (N=306) with median survival of 5.6 years. The graph includes hazard ratio, confidence interval, P-value, and subject numbers at risk over time.*

FDA Label Image

Figure (Sunitinib Fig4)

Kaplan-Meier plot showing progression-free survival probability over time (in months) comparing Sunitinib Malate (N=86) and placebo (N=85). The median progression-free survival is 10.2 months for Sunitinib Malate and 5.4 months for placebo, with corresponding subject numbers at risk displayed below the x-axis. Hazard ratio and confidence interval data are also shown.*

FDA Label Image

Package Label-principal Display Panel (12.5 mg (28 Capsules Bottle))

Label for Sunitinib Malate Capsules 12.5 mg by Aurobindo Pharma Limited, containing 28 capsules. The label includes dosage information, storage instructions, and the distributor's address: Aurobindo Pharma USA, East Windsor, NJ. It states the capsules contain 12.5 mg sunitinib equivalent to 16.71 mg sunitinib malate and notes that the medication guide should be dispensed separately.*

FDA Label Image

Package Label-principal Display Panel (12.5 mg 28 Capsules (4 x 7 Unit-Dose))

Sunitinib Malate Capsules 12.5 mg unit-dose carton with 28 capsules (4 x 7 unit-dose) by Aurobindo Pharma Limited. The label includes dosage strength, NDC 59651-464-29, storage instructions, and distributor details for Aurobindo Pharma USA, Inc. The packaging features a white background with maroon and blue accents and a barcode.*

FDA Label Image

Package Label-principal Display Panel (25 mg 28 Capsules (4 x 7 Unit-Dose))

Sunitinib Malate Capsules 25 mg label showing dispensing information, storage conditions, and distributor details. The label includes the NDC 59651-465-28, a quantity of 28 capsules, and states the drug is distributed by Aurobindo Pharma USA, Inc. The capsules contain 25 mg sunitinib equivalent to 33.41 mg sunitinib malate and are made in India.*

FDA Label Image

Package Label-principal Display Panel (25 mg 28 Capsules (4 x 7 Unit-Dose))

Packaging label for Sunitinib Malate Capsules 25 mg by Aurobindo Pharma USA, Inc. The label indicates 28 capsules in a 4 x 7 unit-dose package. It includes storage instructions, a barcode, NDC 59651-465-29, and a note for pharmacists to dispense the Medication Guide to patients. The product is made in India.*

FDA Label Image

Package Label-principal Display Panel (37.5 mg (28 Capsules Bottle))

Label for Sunitinib Malate Capsules 37.5 mg by Aurobindo Pharma USA, Inc. It includes NDC 59651-466-28 and contains 28 capsules. The label states dosage information, storage instructions, and distribution details, including the manufacturer's address in East Windsor, NJ, and that the product is made in India.*

FDA Label Image

Str (Sunitinib Str)

Chemical structure of sunitinib malate, showing the molecular arrangement of atoms, including rings, functional groups, and bonds representing the active ingredient in SUNITINIB MALATE capsules by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.